Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inui Immunotherapy Clinic is a specialized medical institution based in Japan that focuses on advanced cancer immunotherapy. The clinic provides personalized treatment regimens utilizing autologous immune cells, including dendritic cell vaccines, natural killer (NK) cell therapy, and alpha-beta T-cell therapy. Led by Dr. Yoichi Inui, the facility emphasizes a holistic approach to oncology, aiming to enhance the patient's own immune system to target and eliminate cancer cells. Their services are primarily offered to patients with various stages of solid tumors who are seeking integrative or alternative therapeutic options alongside standard care. The clinic operates facilities in major Japanese cities like Osaka and Tokyo, catering to both domestic and international patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inui Immunotherapy Clinic.